Study to Assess an Interphase Cycle With Flotetuzumab.
Clinical trial NCT05063123 · WITHDRAWN
Trial details
- NCT number
- NCT05063123
- Sponsor
- Stichting Hemato-Oncologie voor Volwassenen Nederland
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-01
- Primary completion
- 2024-08-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.